3 New Strong Buy Ratings from Top-Rated Analysts: 03/12/2026
All of these stocks have Buy or Strong Buy ratings in our Zen Ratings system — and they’re all adored by top-rated analysts.
- Orion Group Holdings (ORN) — 582% earnings growth forecast backs this construction play
- Ciena Corp (CIEN) — Analysts see an optics "supercycle" fueling this telecom giant
- BrightSpring Health Services (BTSG) — Up 277% since listing and still climbing
P.S. Want more high-potential stocks? Check out our recent video featuring 6 hidden gem stocks under $35
A note from our sponsors...
At Any Given Moment, Only 8% of Stocks Are Worth Owning The other 92%? They'll waste your time, your money, or both. Louis Navellier has spent 47 years building a system that separates the 8% from everything else - and he's offering 3 FREE searches so you can see where your stocks fall. A? B? C? F? Find out in seconds. No credit card required. See Which Grade Your Stocks Earn.1. Orion Group Holdings Inc (NYSE: ORN)
Orion Group Holdings just posted a Q4 earnings beat — and it's not slowing down. With the strategic acquisition of J.E. McAmis bolstering its marine capabilities, this infrastructure and construction specialist now sits on a $23 billion opportunity pipeline spanning the U.S., Canada, and the Caribbean. Here's why that matters.
Zen Rating: B (Buy) — see full analysis
Recent Price: $11.71 — get current quote
Max 1-year forecast: $17.00
Why we're watching:
- Analyst support: ORN enjoys unanimous Strong Buy ratings from all 4 covering analysts, demonstrating exceptional Wall Street confidence in the company's trajectory. See the ratings
- B. Riley Securities analyst Alex Rygiel (a top 1% rated analyst) recently maintained his Strong Buy rating and raised his price target to $17, noting that Q4's $233.2M contract revenue and $0.08 EPS beat consensus estimates, while an early Q1 $86.3M U.S. Army Corps project highlights momentum in Marine capabilities.
- DA Davidson's Brent Thielman (a top 2% rated analyst) recently maintained his Strong Buy rating with a $15 price target, reflecting confidence in the company's execution capabilities.
- Exceptional forecasted earnings growth: The company's earnings growth is forecast at an extraordinary 582% over the next year, driven by improved project execution, strategic acquisitions, and a massive $23 billion pipeline of opportunities.
- Industry ranking context: ORN is currently the 7th highest-rated stock out of 40 in the Engineering & Construction industry, which has an Industry Rating of A.
- Zen Rating highlights: As a B-rated stock, ORN is in the second-highest tier of stocks we track — a category that has traditionally delivered nearly 20% annual returns.
- Component Grades: The stock shows strength with B grades in Growth, Momentum, and Financials, indicating solid fundamentals and positive market sentiment supporting its recovery trajectory. See all 7 Zen Component Grades here
2. Ciena Corp (NYSE: CIEN)
Analysts are sounding the alarm — and this time, it's bullish. Ciena, a key player powering the networks behind major telecom and cloud giants, just earned fresh upgrades from top analysts betting on an incoming optics "supercycle." Ranked #9 in Communication Equipment, Ciena could be riding the next big wave in cloud spending. Here's what investors need to know.
Zen Rating: B (Buy) — see full analysis
Recent Price: $338.00 — get current quote
Max 1-year forecast: $380.00
Why we're watching:
- Analyst support: Strong conviction from Wall Street with 7 Strong Buy ratings, 1 Buy rating, and 4 Hold ratings among 12 analysts, delivering a Strong Buy consensus. See the ratings
- JP Morgan's Samik Chatterjee (a top 1% rated analyst) recently raised his price target to $380 (the highest on the Street), expressing increased confidence in the sustainability of Ciena's revenue growth despite near-term supply visibility concerns.
- Rosenblatt analyst Mike Genovese (a top 1% rated analyst) maintained his Strong Buy rating with a $350 price target following the company's Q1 earnings beat.
- Additional top-tier support includes Atif Malik (Citigroup, top 1%), Tim Long (Barclays, top 5%), Ruben Roy (Stifel Nicolaus, top 1%), and Ryan Koontz (Needham, top 1%), all maintaining bullish outlooks.
- Awesome earnings forecast: The company's earnings are forecast to surge 238% over the next year to $5.44 per share, with revenue growth of 18.4% driven by robust demand for optical networking infrastructure supporting AI and cloud buildouts.
- Industry ranking context: CIEN is currently the 9th highest-rated stock in the Communication Equipment industry, which has an Industry Rating of B.
- Zen Rating highlights: CIEN earns a B rating overall, indicating it’s an above-average pick among the 4600+ stocks we track.
- Component Grades: Ciena demonstrates excellence with an A grade in Growth which underscores its strong expansion potential in the optical networking supercycle, complemented by B grades in Momentum, Sentiment, Safety, and Financials, reflecting a well-rounded investment profile. See all 7 Zen Component Grades here
3. Brightspring Health Services (NASDAQ: BTSG)
A 277% return in just over two years — and BrightSpring Health Services is still climbing. Since its January 2024 listing, this home and community-based healthcare powerhouse has rewarded investors through relentless operational execution and strategic growth. Now ranked #5 in Health Information Services, BrightSpring is proving that betting on healthcare at home is paying off big. Here's why the momentum may just be getting started.
Zen Rating: B (Buy) — see full analysis
Recent Price: $41.34 — get current quote
Max 1-year forecast: $55.00
Why we're watching:
- Analyst support: Wall Street shows strong conviction with 7 Strong Buy ratings and 2 Buy ratings among 9 covering analysts, delivering an overwhelming Strong Buy consensus. See the ratings
- Morgan Stanley researcher Erin Wright (a top 5% rated analyst) recently maintained her Strong Buy rating with a $48 price target, representing nearly 16% upside potential.
- Mizuho analyst Ann Hynes (a top 11% rated analyst) recently maintained her Buy rating with a $50 price target, reflecting confidence in the company's growth trajectory.
- The company's earnings are projected to grow 47.5% over the next year to $1.39 per share, with continued expansion to $1.72 in year two, supported by strong revenue growth of 16.4% and expanding margins.
- Industry ranking context: BTSG is currently the 4th highest-rated stock out of 46 in the Health Information Service industry, which has an Industry Rating of C.
- Zen Rating highlights: As a B or Buy-rated stock, BTSG has passed our 115-factor review with above-average marks that indicate it’s in a tier of stocks that have traditionally delivered nearly 20% annual returns.
- Component Grades: The company excels with an A grade in Growth, along with B grades in Momentum, Safety, and Financials, demonstrating solid operational execution and market momentum. See all 7 Zen Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.